Dr. Hans Hofland

Dr. Hans Hofland, Erasmus MC

Hans Hofland is a clinical endocrinologist and associate professor in the field of endocrine oncology at the Erasmus MC, Rotterdam, where he heads the ENETS Center of Excellence and is the medical lead for radionuclide therapy. His main research interests are in developing novel biomarkers and therapeutic options for patients with neuroendocrine tumors. Particular focus has been on the molecular characterization and treatment of functioning NET, including carcinoid syndrome and pancreatic syndromes, and on improving radionuclide therapy for NET and other endocrine tumors.